This document is page 47 of a 2017 report by Ackrell Capital, LLC regarding 'Cannabis Industry Segmentation.' It provides a technical overview of cannabis concentrates, specifically comparing solvent-based (hydrocarbon, CO2, ethanol) and solvent-free extraction methods. It includes market data from Q3 2017 for Colorado, Oregon, and Washington provided by BDS Analytics. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional document production, the text contains no references to Jeffrey Epstein, associates, or specific financial transactions.
This document is page 42 of a 'Cannabis Investment Report' published by Ackrell Capital in December 2017. It analyzes the regulatory requirements for cannabis dispensaries, specifically regarding state licensing and compliance ('seed to sale' tracking). The report highlights the density of dispensaries in Colorado compared to Starbucks and McDonald's locations and discusses the emerging role of e-commerce and mobile applications in the cannabis sector, noting current federal restrictions on interstate commerce. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a production for a Congressional investigation.
This document is page 7 of an executive summary by Ackrell Capital regarding the U.S. Legalized Cannabis Market. It contains a chart projecting market growth and consumer numbers from 2016 to 2030. The text focuses on trends to watch in 2018, specifically the impact of recreational legalization in California and Canada. The document bears a 'HOUSE_OVERSIGHT_024643' stamp, but the content is strictly related to cannabis market analysis and contains no mention of Jeffrey Epstein or related associates.
This document is page 4 of a Cannabis Investment Report by Ackrell Capital dated December 2017. It analyzes the U.S. state-legal cannabis market, estimating a total value of $8.0 billion with specific breakdowns for California, Colorado, Washington, and Oregon. The text discusses the legal conflict between state legalization and federal prohibition, noting the lack of bankruptcy protections and banking access, while highlighting DOJ and Treasury policies that have allowed the industry to operate. The document contains the Bates stamp HOUSE_OVERSIGHT_024640, indicating it is part of a House Oversight Committee production.
This document is a transcript page from a House Oversight collection (Bates stamp 029027) featuring an interview with Steve Bannon. Bannon discusses the growth of his media organization (likely Breitbart) relative to Fox News, the rise of a 'global tea party movement,' and populist sentiments against the 'party of Davos' and centralized governments. He specifically references reporting on UKIP and Front National, his time at Goldman Sachs, and offers a warning about Vladimir Putin's intelligence and appeal to social conservatives.
This document is a political analysis report produced by Laffer Associates, dated July 6, 2016. It presents statistical tables comparing Republican and Democrat voter turnout in various state primaries and caucuses between 2008, 2012, and 2016. The analysis concludes that the data should be concerning for Hillary Clinton's presidential campaign. The document bears a House Oversight Committee stamp, suggesting it was part of a document production for a congressional investigation.
This document is page 62 of a Cowen Collaborative Insights report dated February 25, 2019, analyzing the CBD market. It provides detailed profiles of four companies: Mary's Whole Pet/Nutritionals, Mile High Labs, Papa & Barkley, Recess, and Reliva CBD Wellness, discussing their products, funding, and strategies. The document bears a 'HOUSE_OVERSIGHT' footer, indicating it was part of materials reviewed by the House Oversight Committee.
This document is page 55 of a Cowen financial research report dated February 25, 2019, analyzing the cannabis and CBD market. It details the business models, revenues, and strategies of companies including Curaleaf, CV Sciences, Elixinol, and Green Thumb Industries (Beboe). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely produced as part of a congressional investigation, though no specific Epstein connection is mentioned in the text of this page.
This document is page 16 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019. It analyzes U.S. hemp production, providing a statistical table of planted acres by state for 2017 and 2018, showing a significant increase in total acreage. The text discusses economic challenges for the hemp CBD market, including supply saturation and seed costs. While marked with a 'HOUSE_OVERSIGHT' Bates number, this specific page contains no direct mention of Jeffrey Epstein, his associates, or victims; it appears to be part of a larger financial document production.
This document is a page from an Ackrell Capital report listing the 'Top 100 Private Cannabis Companies 2018'. It contains a categorized list of 100 entities in the cannabis industry, a standard investment disclaimer footer, and a Bates stamp indicating it is part of a House Oversight Committee investigation (HOUSE_OVERSIGHT_024815). No specific individuals, aircraft, or direct communications are listed on this page.
This document is page 154 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It contains corporate profiles for four cannabis-industry companies: Meadow, Merry Jane, MiNDFUL, and MJ Freeway. The document bears a 'HOUSE_OVERSIGHT_024790' Bates stamp, indicating it was part of a document production to the House Oversight Committee, though the page content itself does not mention Jeffrey Epstein.
This document is page 153 of an Ackrell Capital report titled 'Chapter VIII Top 100 Private Cannabis Companies 2018'. It provides business profiles for four companies: Level Blends, LivWell Enlightened Health, Lunchbox Alchemy, and Mary's Medicinals. The page bears the Bates stamp 'HOUSE_OVERSIGHT_024789', indicating it is part of a document production for a House Oversight Committee investigation, though no direct connection to Jeffrey Epstein is explicitly mentioned in the text of this specific page.
This document is page 149 of an Ackrell Capital report titled 'Chapter VIII Top 100 Private Cannabis Companies 2018'. It profiles four specific companies: Green Dot Labs, Green Flower Media, Green Rush, and The Green Solution, providing their locations, websites, and brief business descriptions. The document bears a Bates stamp 'HOUSE_OVERSIGHT_024785', indicating it was part of a document production for the House Oversight Committee.
This document is page 148 of a Cannabis Investment Report produced by Ackrell Capital, LLC in December 2017. It provides business profiles for four companies: FunkSac, Garden State Dispensary, GFarmaLabs, and Gold Coast Extracts. The document bears a Bates stamp 'HOUSE_OVERSIGHT_024784', indicating it was part of a document production to the House Oversight Committee.
This document is page 147 of a report by Ackrell Capital titled 'Chapter VIII Top 100 Private Cannabis Companies 2018'. It provides business profiles for four specific companies: Evolve Therapeutics, Evoxe Laboratories, Flow Kana, and Flowhub, detailing their locations, websites, and operational focuses (biopharma, vaporizers, flower production, and software respectively). The document bears a 'HOUSE_OVERSIGHT_024783' Bates stamp, indicating it was part of a document production to the US House Oversight Committee.
This document is page 146 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It provides corporate profiles for four cannabis-related companies: Eaze Solutions, Eel River Organics, Elemental Wellness, and Euflora. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024782', indicating it was part of a production to the House Oversight Committee, likely regarding financial investigations.
This document is page 143 from a 2018 Ackrell Capital report titled 'Top 100 Private Cannabis Companies.' It profiles four specific companies: CannaCraft, CannaKorp, Colorado Harvest Company, and Columbia Care, detailing their locations, websites, and business models. The document bears a 'HOUSE_OVERSIGHT_024779' Bates stamp, indicating it was collected as evidence during a House Oversight Committee investigation, likely related to financial probes.
This document is page 140 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It profiles four companies in the cannabis industry: Auntie Dolores, Baker Technologies, BAS Research, and BDS Analytics. The document bears a Bates stamp 'HOUSE_OVERSIGHT_024776', indicating it is part of a document production to the House Oversight Committee, likely related to financial investigations, though no direct mention of Jeffrey Epstein appears on this specific page.
This document is page 105 of a 2017 financial report by Ackrell Capital regarding the U.S. State-Legal Cannabis Market. It estimates the 2017 market value at $8.0 billion, provides a pie chart breaking down revenue by state (California, Colorado, Washington, Oregon), and discusses recreational sales as a key driver for market expansion. The page bears the stamp 'HOUSE_OVERSIGHT_024741', indicating it was part of a document production for the House Oversight Committee.
This document is a biographical profile of U.S. Congresswoman Diana DeGette (D-CO), likely prepared as a briefing material. It details her legislative roles, specifically her leadership in the 111th Congress, her work on the Energy and Commerce Committee, and her advocacy for stem-cell research. The document bears a 'HOUSE_OVERSIGHT' bates stamp, suggesting it was part of a document production for a Congressional investigation.
This document appears to be page 100 of a legal review article authored by Paul Cassell (a lawyer for Epstein's victims), submitted as evidence to the House Oversight Committee. The text analyzes state laws (CO, MO, NJ, MA, ID) that extend victims' rights to the pre-charge stage and require prosecutor consultation regarding plea agreements. This legal argument is central to the Epstein case controversy, specifically regarding the secret Non-Prosecution Agreement signed before federal charges were filed.
This document appears to be a page from a news article (likely Bloomberg) included in a House Oversight Committee file. It discusses the implementation of tax incentives (likely Opportunity Zones) in Boulder, Colorado, and a subsequent 18-month development moratorium imposed by local officials. Council member Bob Yates is quoted discussing the balance between development, affordable housing, and the town's socioeconomic divide. While part of a larger investigative file (potentially related to tax incentive abuse), this specific page does not mention Jeffrey Epstein.
This document is a financial research note from Bank of America Merrill Lynch, dated November 17, 2016, summarizing discussions from its 'Future of Financials Conference'. It analyzes investor sentiment towards GWB, noting concerns about its agricultural loan exposure, and provides a positive outlook ('Buy' rating) for IBERIABANK (IBKC), anticipating benefits from pro-growth policies under the Trump administration. The document contains no information related to Jeffrey Epstein.
This document is the cover sheet and index for the videotaped deposition of Tony Figueroa, taken on June 28, 2016, in the civil case of Virginia Giuffre v. Ghislaine Maxwell (15-cv-07433-RWS). The deposition occurred in Palm Coast, Florida, with attorneys for both parties present. The document lists the attendees, legal counsel, and an index of exhibits presented by both the defendant and plaintiff, which include police reports, photos, and a passport.
This document, produced by EY and labeled HOUSE_OVERSIGHT_022374, is a political analysis of the 2016 US election results. It discusses the Republican party's control of the White House and Congress and provides a detailed breakdown of outcomes in key Senate races across multiple states. This document is exclusively about US politics and contains no information, mentions, or connections to Jeffrey Epstein or any related subjects.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity